A variety of neuropharmacological agents were tested to elucidate how chlorpromazine influenced an endotoxin-induced reaction. The results obtained, particularly with beta-adrenergic blocking agents, reserpine and fusaric acid, suggested that the primary locus of chlorpromazine's action was mediated by peripheral beta-adrenergic receptor blockade. Such a locus is compatible with the low doses of propranolol which suppress the reaction, and with successful treatment of shock with dopamine.
Introduction
Where endotoxin has been implicated as a cause of eclampsia or septic shock in man (McKay 1965) , knowledge of the pharmacological basis of the endotoxin-induced reaction may be helpful in selecting the appropriate therapy. Suppression of these reactions in animals by a variety of mainly psychotropic agents enabled mediators to be identified.
Methods

Mousemodels
Two mouse models and the changes produced by endotoxin in these models are fully described by Wright (1980) and summarized below. The two principal factors investigated in these animal models were the fall in white blood cell (WBC) and platelet counts. The ability of a number of drugs to prevent these changes was recorded. Model I: Escherichia coli lipopolysaccharide 100 ug dissolved in saline was given twice intravenously to six-week old inbred CBAjCA mice at 20-hour intervals. After the second inoculation there was an immediate fall in temperature and number of WBC and platelets, which was reversible in three hours. A transient release of endotoxin in the peripheral circulation of the mouse was demonstrated by the Limulus lysate assay test (Reinhold & Fine 1971 ). For each drug tested 42 mice were employed in seven groups, six in each group. Three groups were given two spaced injections of lipopolysaccharide, two with the second injection of lipopolysaccharide being preceded by test drug or diluent. Two groups had two spaced injections, in one group the first was diluent and the second lipopolysaccharide, while the reversed order obtained in the second group. One group received test agent alone and one was left uninoculated and used for base-line values. Model 2: The defect of model 1 was an inability to demonstrate the role of endotoxin in an infective septicaemia. The objection was overcome by studying the reaction following treatment of mice infected with Borrelia, the treatment being ampicillin 10 mg given intraperitoneally, the mice having been infected two days previously with a standard inoculum of Borrelia duttoni (Wellcome strain). Following treatment there was an acute fall in temperature, WBC and platelet count with the release of endotoxin-like material into the peripheral circulation. These changes reverted to normal in three to five hours. Borrelia contains an endotoxin-like material and it is this substance which mediates the reaction (Wright 1980 For each drug tested in this model, 48 mice were divided into eight groups, with six in each group. Groups were infected and just treated with ampicillin or with the test agent or diluent used with the agent being given prior to treating the infection. Groups were also studied which were infected and given test agent alone. Uninfected groups were given either the agent or ampicillin alone or together. Lastly, a group was left uninoculated and used for base-line values.
Agents tested
The following agents were used: reserpine, chlorimipramine hydrochloride, desimipramine hydrochloride (all from Ciba-Geigy), pimozide and haloperidol (both from Janssen), nortryptiline hydrochloride and fluoxitine (both from Lilly), indomethacin (MSD), levodopa (Roche), sodium metabisulphite (SM) (Evans Medical), thioridazine hydrochloride, clozapine and methysergide (all from Sandoz), chlorpromazine, cimetidine and tranylcypromine sulphate (all from Smith, Kline and French), phenelzine (William R Warner), naloxone (Winthrop), fusaric acid, n-para-chlorophenylalanine, 5-hydroxytryptamine creatinine sulphate (5HT), histamine disphosphate (all from Sigma Chemicals, Poole). nt-propranolol hydrochloride in water adjusted to pH 3-3.5 with citric acid, oxprenolol hydrochloride as lyophilized powder, phentolamine mesylate in water with anhydrous dextrose and SM, morphine sulphate in water and SM, diphenhydramine in water, adrenaline bitartrate in water with sodium chloride and SM, and atropine sulphate in water adjusted to pH 3 with dilute sulphuric acid, were all obtained from the hospital pharmacy in the form of parenteral administration.
The agents were dissolved and diluted to the appropriate concentration immediately before each experiment with sterile, nonpyrogenic physiological saline. The dose of the drug is expressed in terms of free base or acid. Exceptionally, haloperidol was dissolved in citric acid, reserpine in glacial acetic acid, and levodopa in 0.5% sodium bicarbonate. Nortryptiline, desimipramine, chlorimipramine, tranylcypromine and chlorpromazine were dissolved in ethanol and then diluted in saline.
All the agents were given intraperitoneally one hour before giving the second inoculation of lipopolysaccharide to normal mice or ampicillin to the infected mice, except the following agents which were ineffective at suppressing endotoxin reactions on this regime: chlorpromazine was given intraperitoneally 15 minutes prior to inoculation; noradrenaline, 5HT and fusaric acid were given intraperitoneally 10 minutes before challenge; haloperidol and reserpine were given subcutaneously one hour prior to the second inoculation; parachlorophenylalanine was given 150 mg/kg twice daily three days prior to the experiment. Each specific agent was tested by two separate experiments in each model. All experiments started between 9.30 and 10.15 a.m, to avoid diurnal variation in haematological values.
Results
The results are shown in Table I , which indicates those agents that were effective in suppressing the reactions induced by endotoxin. The mean WBC and mean platelet counts at one hour were compared with controls. Both test and control haematological counts are given as the mean of six readings and averaged with the means from the second (confirmatory) experiment. The resulting mean WBC and platelet counts, with respective standard errors (±), are expressed as a percentage of the control counts. The effects persisted for at least one hour, and sometimes two, in both models. In no instance did the WBC or platelets become uncountable when the agent was shown to be 'protective'. Allowance has been made for the slight reduction in WBC count in the untreated Borrelia infected mice. The pretreatment mean white count was 6.9 ±0.5 x 10 9/1 (normal mean value 9.2 ±0.6 x 10 9 fl) while the mean platelet count was 295± 37 x 10 9/1 (normal value 418 ±44 x 10 9/1). The WBCs were deemed to be uncountable when they fell below 0.8 x 10 9/1 and platelets below 22 x 10 9 /1. Drug amelioration of the fall in temperature during the reaction to endotoxin was not tabulated as certain drugs, such as 5HT or chlorpromazine (CPZ), have an intrinsic hypothermic effect, while indomethacin modified the 'pyrexia' without inhibiting the haematological effects. • Effective in suppressing reactions induced by endotoxin Only critical dose presented: for effective agents the minimum dose, and for ineffective agents the maximum. within the limits of tested range. All agents (except .) tested one hour prior to giving challenge or treatment dose; all agents (except .6.)given intraperitoneally
Discussion
The inhibition of the endotoxin-induced fall in WBC and platelet counts in the animal models by chlorpromazine (CPZ) conforms with the ability of CPZ to prevent endotoxin-induced abortion in mice (Parant & Chedid 1964) .The principal action of CPZ has been shown in the rat to be dopamine (DA) inhibition (O'Keeffe et al. 1970) . Other DA antagonists failed to influence the changes induced by endotoxin in mice, so it appears that the effect of CPZ is not mediated by dopamine blockade. The DA antagonists tested were thioridazine and the much more active haloperidol (O'Keeffe et al. 1970) , clozapine (Sayers et al. 1975 ) and the very specific DA antagonist pimozide (Pinder et al. 1976 , Lemberger et al. 1978 .The effect of the immediate DA precursor levodopa was tested, since shock from any cause is successfully treated with DA in man (Goldberg 1974) .A critical concentration of this metabolite prevented the endotoxin-induced changes in our animal models. There was no testing of enhancement in our animal models.
To test the possibility of CPZ antagonizing 5HT (Costa 1956 , Tonge 1972 , Essman & Cooper 1978 , methysergide, which acts by blocking D receptors for 5HT (Bennett & Snyder Journal oftheRoyal Society ofMedicine Volume 73June 1980 1976), was given to mice in the experimental model. The drug was partially effective in suppressing the reactions, which might be due to methysergide also having an agonist action on SHT (Apperley et al. 1976 )and dopamine receptors (Creese et al. 1975) .
The antidepressive agents, chlorimipramine, desimipramine, fluoxitine and nortryptyline, were next considered. These all inhibit the presynaptic re-uptake of catecholamines, while chlorimipramine and fluoxitine also inhibit SHT uptake (Carlsson, Jonason et al. 1969 , Lemberger et al. 1978 . These drugs were found to inhibit the effects of endotoxin. The secondary amine tricyclics, nortryptyline and desimipramine, not only block the re-uptake of SHT but inhibit noradrenaline re-uptake in both rats and mice (Carlsson et al. 1969a , b, Bopp & Biel 1974 , despite rapid breakdown (Dingell et al. 1964) . Alternatively, the influence of desimipramine and nortryptyline on the endotoxin-induced changes may be the result of blockade of noradrenergic, but not apparently SHT, receptors (Banerjee et al. 1977) . It is of interest that the antidepressants tranylcypromine and phenelzine also suppressed the reactions to endotoxin.
Lemaire and his colleagues (1978) suggested on indirect evidence in rats that naloxone blocks SHT re-uptake. Holaday & Faden (1978) inhibited endotoxin-induced hypotension in rats with naloxone and our experiments preventing endotoxin-induced effects by naloxone parallel their findings. As anticipated, morphine was without influence on the effect of endotoxin.
SHT alone caused partial inhibition at a critical concentration, although the blood-brain barrier is very resistant to penetration by SHT (Robson & Stacey 1962) , implying that antagonism to the endotoxin effects is peripheral and not central in action. SHT and certain other amines can be released outside the nervous system by such cells as mouse mast cells. Some of the effects may be mediated by reflex peripheral nerve stimulation (Plaut & Lichtenstein 1978) , providing a difficulty in disentangling central and peripheral effects in vivo. Para-chlorophenylalanine, which reduced the tissue content of SHT (Koe & Weissman 1966),was ineffective in preventing the expected endotoxin-induced effects. Des Prez &Oates (1968) showed that para-chlorophenylalanine did not influence endotoxin-induced fever in rabbits and suggested that para-chlorophenylalanine depleted brain stem SHT preferentially, again indicating that the site at which SHT antagonism inhibited endotoxin changes was peripheral. The participation of the dopaminergic system could not be entirely excluded as SHT may directly or indirectly stimulate dopamine release (Jacobs 1974 , Walinder et al. 1976 ).
Tricyclic drugs, as well as the non-tricyclic CPZ, are potent antihistamines (Lassen et al. 1975 , Lancet 1978 , Maayani et al. 1978 . Nortryptyline is a powerful HI receptor blocking drug (Green & Maayani 1977) . To exclude an antihistamine effect, the H 2 blocking drug cimetidine (Brimblecombe et al. 1975) , and the predominantly HI blocking drug diphenhydramine (Giordano et al. 1977) , were tested on these animals. Both these agents were found to be ineffective, excluding the anti histaminic effect of tricyclics as an explanation for their action in our models.
Histamine has recently been reported to be capable of preventing endotoxic shock in mice (Markley et al. 1971) ,a finding which we could only confirm using high concentrations of the drug. The mechanism suggested by Markley was that products released by injured tissue attached to certain receptors. These unknown products are alleged to produce deleterious effects and histamine was thought to compete with these receptors. Whatever histamine release occurs after giving endotoxin, adrenaline or noradrenaline can compete for the same receptor site as histamine in species other than mice (Steinberg & Holland 1975 , McGrath & Shepherd 1976 , Lamkin et al. 1976 , Moroni et al. 1977 .
The independent inhibition of the effect of endotoxin by histamine or SHT at very high concentrations is in contrast with Hirata's (1975) results in which both transmitters given simultaneously were needed to demonstrate an endotoxin-inhibiting effect. Hirata may have used suboptimal doses and achieved enhanced effect by combination.
Neither adrenaline, nor phentolamine, an alpha-receptor blocking drug, had any effect on the reaction to endotoxin. The blocking effect of CPZ on peripheral alpha-adrenergic receptors (Anden et al. 1966) is therefore unlikely to be relevant to chlorpromazine's activity in inhibiting endotoxin-induced changes. In contradiction to the claims of Van Arman et al. (1970) that indomethacin was beneficial in endotoxic shock, we found indomethacin ineffective in inhibiting endotoxic changes.
When beta-adrenergic blocking drugs propranolol and oxprenolol were tested, both in 'clinical' dosage were able to block the reactions to endotoxin. The lipophilic propranolol was effective at a slightly lower dosage. Tampier et al. (1977) , like Charalampous & Askew (1974) , have shown that the beta-blocking drug propranolol could displace naloxone binding in brain tissue by competition for the same receptor. This again implicates the beta-adrenergic receptor. Fusaric acid, a powerful dopamine-beta-hydroxylase inhibitor (Hidaka 1971) preventing the formation of adrenaline and noradrenaline, blocked the endotoxin-induced reaction at a high dosage.
It is unlikely that CPZ inhibition of endotoxin-induced changes is mediated by the anticholinergic action (Maickel 1968), as thioridazine, unlike CPZ, fails to prevent endotoxin reactions, although both drugs possess similar anticholinergic properties (Iversen, Rogawski & Miller 1976) . Atropine, which antagonizes muscarinic cholinergic receptors, also failed to prevent the endotoxin-induced changes in mice. Similarly, the other DA antagonists did not inhibit the endotoxin effects, although all have some anticholinergic activity (Snyder et al. 1974 , Iversen, Horn & Miller 1976 ).
An explanation which conforms with the data is that the changes induced by endotoxin in mice are inhibited by monoamines competing for the beta-adrenergic receptor. Tricyclic antidepressants act on the beta-adrenergic receptors in a manner consistent with our model (Vetulani & Sulser 1975 , Vetulani et al. 1976 . CPZ, unlike pimozide or haloperidol, also blocks noradrenergic receptors in the spinal cord of rats (Anden et al. 1970) . A variety of alternative beta-adrenergic inhibitor mechanisms have been reviewed by Williams & Lefkowitz (1978) .The depletion by reserpine of all body catecholamines (Carlsson et al.1957 , Orlans & Brodie 1960 and possibly 5HT (Pletscher et al. 1955) leads to endotoxin reactions being suppressed, while the pyrexia generated by E. coli endotoxin in rabbits is also inhibited by reserpine (Kronenberg & Kurbjuweit 1959 ,Yasuda 1962 .
These experiments suggest that beta-adrenergic activity is of primary importance in mediating endotoxin-induced changes. This view is reinforced by the finding of considerably increased levels of adrenaline and noradrenaline in septicaemic shock in man (Benedict & Grahame-Smith 1978) . It is likely that the beta-blockade is peripheral, since far higher dosages of propranolol (5 to 38 mg/kg) are required to demonstrate the central sedative and anticonvulsant properties of this drug (Leszkovszky & Tardos 1965) . Some postganglionic sympathetic nerve terminals possess dopaminergic receptors which, when activated, mediate inhibition of nerve-evoked noradrenaline release (Steinsland & Hieble 1978) and provide a theoretical justification for Goldberg's regime (Goldberg 1974) in which dopamine is used as an initial therapy for shock.
If our experimental findings are relevant to shock, we would caution against the use of adrenaline, noradrenaline or narcotic drugs and consider that the beta-adrenergic receptor blocking drugs, naloxone, chlorpromazine, dopamine and dopamine agonists may have therapeutic value. However, the benefit of some of these drugs in the ensuing attenuated endotoxin reaction remains unknown.
